I mean I think they can extend if they need or want more time
So 8 weeks can easily be pushed stretched
I don’t mind if it amounts to anything positive for share holders
But I don’t know - I mean who does
I believe it’s 8 weeks from time of administration for them to come with some sort of info for shareholders
I doubt we will get anything but waiting is harder than getting some sort of news
A little life line to scarp up some sort of monies for the shares I hold would be nice
The exact number and situation is as follows, it seems ODX will now receive this sum of money.
'The Company is still owed £628k by Abingdon Health which fell due prior to February 2021 and which is expected to be received in full once Abingdon have concluded a settlement with DHSC'
Really surprised me!
Maybe a late rally in the afternoon or tomorrow?
On that rns I would have at least expected a big rise
Markets always surprises me!
Biggest news we have been waiting for it’s been received
And share price up 4%?
Any explanations?
If I am correct they own like 3.5% of shares in 4d
If that is the case won’t it be in their favour to do something
Or is it very insignificant ?
Thanks
Therefore, the administrators make no statement or representation in respect of any of the matters raised or discussed in advance of or during this Annual General Meeting. The administrators make no comment whatsoever in respect of the AGM Notice including any information on the Company or its equity securities, any statements of belief or intent by the Directors, the resolutions proposed (including any recommendations given by the Directors in relation to them or reasoning for the resolutions) or which may be passed at this meeting, or any answers given by the Directors to questions raised by shareholders in connection with this Annual General Meeting. The Administrators intend to take legal advice as to whether any resolutions that are passed at the meeting are, in all circumstances, legally valid. The administrators make no comment whatsoever on the appropriateness of the convening of the Annual General Meeting or the manner in which the Annual General Meeting is conducted. To the extent that the implementation of any resolutions passed at this Annual General Meeting requires the exercise of a management power pursuant to paragraph 64(1) of Schedule B1 of the Insolvency Act 1986, the administrators have had no opportunity to consider whether such implementation is appropriate for the purposes of the administration and therefore provide no consent in this regard."
At the annual general meeting of 4D pharma plc (AIM: DDDD; Nasdaq: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products, held earlier today, all resolutions put to shareholders were duly passed.
The full text of each resolution was included in the notice of the meeting, which was posted to shareholders on 20 May 2022, and is available on the Company's website www.4dpharmaplc.com.
The results for the resolutions will shortly be available on the Shareholder Information section of the Company's website, www.4dpharmaplc.com.
Ahead of the meeting, the following statement was made:
"On 24 June 2022, David Pike and James Clark of Interpath Advisory were appointed as administrators of the Company. The administrators have had no oversight of or involvement in the preparation or convening of this Annual General Meeting nor in any of the materials circulated to the Company's shareholders in advance of this Annual General Meeting [which for the avoidance of doubt shall include, [but not be limited to], the Notice of Annual General Meeting dated 25 May 2022 ("AGM Notice") or any enclosures or documents referred to therein.]
from DHSC to Abingdon, which is required to be paid to the Company on or before 22 July 2022
Great news about settlement
What would be the next great news?
Orders RNS NEXT?
Great feeling that afternoon will be mega let’s see
This rns is worth around 8p in my opinion
The previous rns were great but because lack of settlement from dhsc it was squashed and not valued
Now we are in a different situation
Time will tell but this catch up share rise is coming big time
My own opinion. Let’s go let’s see
Yes, a few of us spoke to Duncan and Alex for 10 minutes after the AGM. Duncan was very open. Said a UK bank would never have done what OF did. He was shocked they did what they did as he said they knew everything including the heads of terms from another lender but still did what they did. We need a quick solution here as the longer it goes on, the more likely we will get nothing. Gut feeling is that they will get some form of finance deal done but guess the terms won’t be great. Duncan also said Merck would rather pay a lot of money for a drug that has been approved rather than speculate on earlier trial success. Duncan had said they he has had so many meetings recently with fund managers, banks, finance houses, he is now pushing those too.
Again from Daniel in 4d telegram group
Right. Here goes. Duncan looked awful so clearly feeling it. Lots of questions put to Duncan who answered everything. Oxford Finance pulled the deal even though the company had a heads of terms to refinance with a mix of debt and equity. OF knew that but still pulled the plug. The admin guy was there too who said they are trying to rescue this finance deal which will sort everything, they are also talking to OF but the admin guy said a deal
is unlikely. It rests on this finance deal short term, longer term it is about trying other refinance or offers for assets. If it comes to offers, admin are mostly bothered about getting OF and other creditors repaid. Shareholders bottom of the pile. Duncan was asked if they prepack, there will be a lot of very angry shareholders. Duncan said no plans for that, he is a shareholder as is Alex and they want to save 4D. The company did breach on 2 counts. They renegotiated the $7.5m to $5m but had it held in 2 US accounts rather than 1. Technical breech as they could have easily moved the money into one. One shareholder asked the admin guy if they had gone below $5m privately . He said they had. So major breech. They also breeched a balance sheet criteria because the non plc companies held too much in their balance sheet when the Spanish government made a one off payment to cover furlough workers in Spain during Covid. We are where we are. In hindsight Duncan should have done a placing but he had no idea the capital markets would be so difficult. As asked about milestone payments. They think Merck will licence 3 drugs from the JV vaccine work which attracts 5-10m
US$ each. I asked if that could be accelerated. Duncan is in discussions with Merck but said they don’t work quickly. One shareholder who is a scientist with a huge holding asked Duncan after the AGM when Duncan came round and shook hands with Alex and asked if there were any more questions before we left, from 1-10 Duncan , what are your thoughts thus will be saved to trade on AIM, Duncan replied, a very good chance. I hope he is right.
From Daniel on groups
https://threadreaderapp.com/thread/1541444212444614656.html
I believe that ArgoBlockchain is currently the bitcoin miner in the best financial condition. Argo has a strong balance sheet with little debt and strong operating cash flows relative to upcoming machine payments. Argo also has the second-lowest direct bitcoin production cost.
Funny how
Great rns few months back !
Didn’t do placing
Shares fell all the way to 20p from 70p
Insiders selling wouldn’t be surprised
Then concern on funding even tho we were told funding till q4
Then a battered bruised (maybe for show) pre agm meeting
So we didn’t even get the to the agm !
Then now administrators called in
Hmmm all too fast and orchestrated maybe never know!
In a statement, 4D Pharma's board said it "intends to work with the joint administrators on proposals to rescue the company as a going concern, albeit there can be no guarantee that this will be successful".
If it’s genuine that the board are working to save the company then that’s good
But at the moment I don’t trust them and would rather the administrators do the calls hopefully in favour of us shareholders but you do know we come last! :( crumb pickers if any!
Our intention is to try to stabilise the company in the immediate term whilst we assess options for the business. We would encourage any parties interested in acquiring the business to contact us at the earliest opportunity. At this stage, 4D Pharma plc's subsidiaries remain outside of an insolvency process and continue to trade."
Big shot but a good one
2 names come to mind
Pfizer and Merck
Let’s hope they see the valuable science and do a bid war !
Who knows we can only hope at this moment in time.